Literature DB >> 12231358

Versican: a versatile extracellular matrix proteoglycan in cell biology.

Thomas N Wight1.   

Abstract

Versican is a large extracellular matrix proteoglycan that is present in a variety of tissues. Successful cloning of the gene in man, mouse, cow and chicken has revealed the existence of at least four splice variants of versican, which differ in the size of the core protein and the number of glycosaminoglycan chains. The highly interactive nature of versican provides a basis for its importance as a structural molecule, creating loose and hydrated matrices during key events in development and disease; and by interacting either directly with cells or indirectly with molecules that associate with cells to, in part, regulate cell adhesion and survival, cell proliferation, cell migration and extracellular matrix assembly. Several studies within the past two years have confirmed a significant role for versican in regulating cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231358     DOI: 10.1016/s0955-0674(02)00375-7

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  215 in total

Review 1.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

3.  High-resolution microrheology in the pericellular matrix of prostate cancer cells.

Authors:  Nadja Nijenhuis; Daisuke Mizuno; Jos A E Spaan; Christoph F Schmidt
Journal:  J R Soc Interface       Date:  2012-02-08       Impact factor: 4.118

4.  Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.

Authors:  Yuan Tian; Francisco J Esteva; Jin Song; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2012-02-07       Impact factor: 5.911

5.  Effects of cleavage by a disintegrin and metalloproteinase with thrombospondin motifs-4 on gene expression and protein content of versican and aggrecan in the digital laminae of horses with starch gruel-induced laminitis.

Authors:  Le Wang; Erica Pawlak; Philip J Johnson; James K Belknap; Dominique Alfandari; Samuel J Black
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

6.  Distribution and processing of a disintegrin and metalloproteinase with thrombospondin motifs-4, aggrecan, versican, and hyaluronan in equine digital laminae.

Authors:  Erica Pawlak; Le Wang; Philip J Johnson; Gerard Nuovo; Almaz Taye; James K Belknap; Dominique Alfandari; Samuel J Black
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

Review 7.  ADAMTS proteases: key roles in atherosclerosis?

Authors:  Rebecca C Salter; Tim G Ashlin; Alvin P L Kwan; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2010-07-22       Impact factor: 4.599

8.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

9.  Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells.

Authors:  B Joddar; S Ibrahim; A Ramamurthi
Journal:  Biomaterials       Date:  2007-06-14       Impact factor: 12.479

10.  GORAB promotes embryonic lung maturation through antagonizing AKT phosphorylation, versican expression, and mesenchymal cell migration.

Authors:  Ying Liu; Xi Chen; Yeon Ja Choi; Ning Yang; Zhongya Song; Elizabeth R Snedecor; Wei Liang; Elaine Lai-Han Leung; Lianfeng Zhang; Chuan Qin; Jiang Chen
Journal:  FASEB J       Date:  2020-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.